GlaxoSmithKline’s Benlysta has been on the market for almost ... Originally approved in 2011 as an IV therapy for adults with SLE, a debilitating autoimmune disease, GSK got a green light ...

A new report about the The Elder Scrolls IV: Oblivion Remake has revealed when the game is releasing, and it’s soon. The report doesn’t provide a precise release date, but a release window.

It is notoriously hard to treat effectively. Saphnelo will compete in the market most closely with GlaxoSmithKline's BLyS inhibitor Benlysta (belimumab), which has been available in the EU to ...

Prince Karim al-Husseini, who was the Aga Khan IV, died in Lisbon on Tuesday (February 4). He was 88. Considered to be a direct descendant of the Prophet Muhammad through his daughter Fatima and ...

Although this is true for many people with iron deficiency, it can be much more complicated. When determining which iron therapy—oral or intravenous (IV)—is right for you, it is important to consider ...

Correspondence to Dr Dimitrios T Boumpas, Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, "Attikon" University Hospital, Joint Academic Rheumatology Program, National ...